GlassScriptPhysician profile
Anna Liveris
NPI 1477895266
$5,590.78
in general payments reported to CMS, 2019-2025
12 companies · $5,222 in 2025
The $5,222 reported for 2025 was more than what 89% of Trauma Surgery providers received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $167 · 2022: $29.41 · 2023: $42.61 · 2024: $130 · 2025: $5,222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,040 · Travel and Lodging: $966 · Food and Beverage: $388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,040.00 |
| Travel and Lodging | $966.31 |
| Food and Beverage | $387.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,048.99 | 2025 | |
| Medline Industries LP | $99.77 | 2020 | |
| Kerecis Limited | $91.46 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Solventum Corporation | $73.61 | 2024-2025 | V.A.C. Veraflo, V.A.C. Veraflo Cleanse Choice, V.A.C.Ulta |
| Teleflex LLC | $56.88 | 2024-2025 | Arrow, Quikclot |
| Davol INC. | $42.61 | 2023 | Phasix Mesh |
| Boston Scientific Corporation | $40.55 | 2024 | Spyglass Discover |
| Csl Behring | $40.00 | 2024 | Kcentra |
| Z-Medica, LLC | $31.66 | 2020 | |
| Avanos Medical | $29.41 | 2022 | |
| Organogenesis INC. | $18.69 | 2020 | |
| Polynovo North America LLC | $17.15 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Liveris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.